Evidence map›Paper›PMID 31195640›Full record

ReviewMolecules (Basel, Switzerland)2019

Structural Modifications of Nature-Inspired Indoloquinolines: A Mini Review of Their Potential Antiproliferative Activity.

Ning Wang, Marta Świtalska, Li Wang, Elkhabiry Shaban, Md Imran Hossain, Ibrahim El Tantawy El Sayed, Joanna Wietrzyk, Tsutomu Inokuchi

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Indolo[2,3-Dalton transactions (Cambridge, England : 2003) · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Highly Antiproliferative Latonduine and Indolo[2,3-Journal of medicinal chemistry · 2022
    Article
  11. Article
  12. Review
  13. In Vitro and In Vivo Antitumor Activity of Indolo[2,3-Molecules (Basel, Switzerland) · 2021
    Article
  14. Review
  15. Antitumoral Properties of Natural Products.Molecules (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ning WangDivision of Chemistry and Biotechnology, Graduate School of Natural Science and Technology, Okayama University, 3-1-1 Tsushima-naka, Kita-ku, Okayama 700-8530, Japan. wn12171982@sina.com.
Marta ŚwitalskaHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12R. Weigla Street, 53-114 Wroclaw, Poland. switalska@iitd.pan.wroc.pl.
Li WangDivision of Chemistry and Biotechnology, Graduate School of Natural Science and Technology, Okayama University, 3-1-1 Tsushima-naka, Kita-ku, Okayama 700-8530, Japan. liwang_512@163.com.ORCID 0000-0003-0284-5958
Elkhabiry ShabanDivision of Chemistry and Biotechnology, Graduate School of Natural Science and Technology, Okayama University, 3-1-1 Tsushima-naka, Kita-ku, Okayama 700-8530, Japan. shaban_nrc@yahoo.com.
Md Imran HossainDivision of Chemistry and Biotechnology, Graduate School of Natural Science and Technology, Okayama University, 3-1-1 Tsushima-naka, Kita-ku, Okayama 700-8530, Japan. imranju7@yahoo.com.
Ibrahim El Tantawy El SayedDivision of Chemistry and Biotechnology, Graduate School of Natural Science and Technology, Okayama University, 3-1-1 Tsushima-naka, Kita-ku, Okayama 700-8530, Japan. ibrahimtantawy@yahoo.co.uk.
Joanna WietrzykHirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 12R. Weigla Street, 53-114 Wroclaw, Poland. wietrzyk@iitd.pan.wroc.pl.ORCID 0000-0003-4980-6606
Tsutomu InokuchiDivision of Chemistry and Biotechnology, Graduate School of Natural Science and Technology, Okayama University, 3-1-1 Tsushima-naka, Kita-ku, Okayama 700-8530, Japan. inokuchi@cc.okayama-u.ac.jp.ORCID 0000-0002-4709-808X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cryptolepine, neocryptolepine and isocryptolepine are naturally occurring indoloquinoline alkaloids with various spectrum of biological properties. Structural modification is an extremely effective means to improve their bioactivities. This review enumerates several neocryptolepine and isocryptolepine analogues with potent antiproliferative activity against MV4-11 (leukemia), A549 (lung cancer), HCT116 (colon cancer) cell lines in vitro. Its activity towards normal mouse fibroblasts BALB/3T3 was also evaluated. Furthermore, structure activity relationships (SAR) are briefly discussed. The anticancer screening of neocryptolepine derivatives was performed in order to determine their cytotoxic and growth inhibitory activities across the JFCR39 cancer cell line panel.

Indexed as

AnimalsCell DeathCell ProliferationHumansIndolesQuinolinesIndolesQuinolinesantiproliferative activitycryptolepineisocryptolepineneocryptolepinestructure activity relationships

Identifiers

PMID31195640
PMCPMC6600460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.